Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene

Carsten Tschöpe; Frank Spillmann; Uwe Rehfeld; Matthias Koch; Dirk Westermann; Christine Altmann; Andreas Dendorfer; Thomas Walther; Michael Bader; Martin Paul; Heinz Peter Schultheiss; Roland Vetter

doi:10.1096/fj.04-1614fje

Improvement of defective sarcoplasmic reticulum Ca²⁺ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene

Carsten Tschöpe^*, Frank Spillmann, Uwe Rehfeld, Matthias Koch, Dirk Westermann, Christine Altmann, Andreas Dendorfer, Thomas Walther, Michael Bader, Martin Paul, Heinz Peter Schultheiss, Roland Vetter

^*Korrespondierende/r Autor/-in für diese Arbeit

Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

27 Zitate (Scopus)

Abstract

Transgenic cardiac expression of the bradykinin (BK) -forming enzyme human tissue kallikrein 1 (hKLK1) in rats is known to attenuate the development of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy. To examine whether improved diastolic and systolic performance in diabetic hKLK1-expressing hearts may be due to rescued sarcoplasmic reticulum (SR) Ca2+ handling, we studied left ventricular (LV) function and Ca2+-ATPase(SERCA2a)-catalyzed SR Ca2+ transport after induction of streptozotocin (STZ) -induced diabetes mellitus in transgenic rats (TGR) expressing the hKLK1 gene.

Originalsprache	Englisch
Zeitschrift	FASEB Journal
Jahrgang	18
Ausgabenummer	15
Seiten (von - bis)	1967-1969
Seitenumfang	3
ISSN	0892-6638
DOIs	https://doi.org/10.1096/fj.04-1614fje
Publikationsstatus	Veröffentlicht - 01.12.2004

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Dokumente

10.1096/fj.04-1614fje

Weitere Links

Link to publication in Scopus

Zitieren

Tschöpe, C., Spillmann, F., Rehfeld, U., Koch, M., Westermann, D., Altmann, C., Dendorfer, A., Walther, T., Bader, M., Paul, M., Schultheiss, H. P., & Vetter, R. (2004). Improvement of defective sarcoplasmic reticulum Ca²⁺ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. FASEB Journal, 18(15), 1967-1969. https://doi.org/10.1096/fj.04-1614fje

@article{82993abc720b4eeeb00c9bdff7198a87,

title = "Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene",

abstract = "Transgenic cardiac expression of the bradykinin (BK) -forming enzyme human tissue kallikrein 1 (hKLK1) in rats is known to attenuate the development of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy. To examine whether improved diastolic and systolic performance in diabetic hKLK1-expressing hearts may be due to rescued sarcoplasmic reticulum (SR) Ca2+ handling, we studied left ventricular (LV) function and Ca2+-ATPase(SERCA2a)-catalyzed SR Ca2+ transport after induction of streptozotocin (STZ) -induced diabetes mellitus in transgenic rats (TGR) expressing the hKLK1 gene. ",

author = "Carsten Tsch{\"o}pe and Frank Spillmann and Uwe Rehfeld and Matthias Koch and Dirk Westermann and Christine Altmann and Andreas Dendorfer and Thomas Walther and Michael Bader and Martin Paul and Schultheiss, \{Heinz Peter\} and Roland Vetter",

year = "2004",

month = dec,

day = "1",

doi = "10.1096/fj.04-1614fje",

language = "English",

volume = "18",

pages = "1967--1969",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "John Wiley \& Sons Inc.",

number = "15",

}

Tschöpe, C, Spillmann, F, Rehfeld, U, Koch, M, Westermann, D, Altmann, C, Dendorfer, A, Walther, T, Bader, M, Paul, M, Schultheiss, HP & Vetter, R 2004, 'Improvement of defective sarcoplasmic reticulum Ca²⁺ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene', FASEB Journal, Jg. 18, Nr. 15, S. 1967-1969. https://doi.org/10.1096/fj.04-1614fje

TY - JOUR

T1 - Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene

AU - Tschöpe, Carsten

AU - Spillmann, Frank

AU - Rehfeld, Uwe

AU - Koch, Matthias

AU - Westermann, Dirk

AU - Altmann, Christine

AU - Dendorfer, Andreas

AU - Walther, Thomas

AU - Bader, Michael

AU - Paul, Martin

AU - Schultheiss, Heinz Peter

AU - Vetter, Roland

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Transgenic cardiac expression of the bradykinin (BK) -forming enzyme human tissue kallikrein 1 (hKLK1) in rats is known to attenuate the development of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy. To examine whether improved diastolic and systolic performance in diabetic hKLK1-expressing hearts may be due to rescued sarcoplasmic reticulum (SR) Ca2+ handling, we studied left ventricular (LV) function and Ca2+-ATPase(SERCA2a)-catalyzed SR Ca2+ transport after induction of streptozotocin (STZ) -induced diabetes mellitus in transgenic rats (TGR) expressing the hKLK1 gene.

AB - Transgenic cardiac expression of the bradykinin (BK) -forming enzyme human tissue kallikrein 1 (hKLK1) in rats is known to attenuate the development of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy. To examine whether improved diastolic and systolic performance in diabetic hKLK1-expressing hearts may be due to rescued sarcoplasmic reticulum (SR) Ca2+ handling, we studied left ventricular (LV) function and Ca2+-ATPase(SERCA2a)-catalyzed SR Ca2+ transport after induction of streptozotocin (STZ) -induced diabetes mellitus in transgenic rats (TGR) expressing the hKLK1 gene.

UR - https://www.scopus.com/pages/publications/10044241544

U2 - 10.1096/fj.04-1614fje

DO - 10.1096/fj.04-1614fje

M3 - Journal articles

C2 - 15448111

AN - SCOPUS:10044241544

SN - 0892-6638

VL - 18

SP - 1967

EP - 1969

JO - FASEB Journal

JF - FASEB Journal

IS - 15

ER -